Drug Topics

AUGUST 6, 2024

From expanding vaccination coverage to battling with PBMs, the community pharmacist has the ability to promote change like never before.

Vaccines 205

Vaccines 205

STAT

AUGUST 6, 2024

WASHINGTON — With Minnesota Gov. Tim Walz as her running mate, Vice President Kamala Harris has tapped a fiery advocate for public health and abortion rights. Harris is said to have chosen Walz as her vice presidential pick as of Tuesday morning, according to multiple news reports, and is expected to officially announce Walz at a rally in Philadelphia, Penn., on Tuesday evening.

145

145

Drug Topics

AUGUST 6, 2024

The COVID-19 pandemic led to increased pharmacist burnout and workforce shortages. The impact is still being felt today.

219

219

Fierce Healthcare

AUGUST 6, 2024

A federal appeals court has upheld a lower court decision that struck down key parts of legislation aimed at reforming surprise medical billing. | A federal appeals court upheld a lower court decision that struck down key parts of legislation aimed at reforming surprise medical billing.

141

141

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

AUGUST 6, 2024

Researchers tested various text-to-image generation platforms to better understand issues of representation within artificial intelligence.

138

138

Pharmacy Times

AUGUST 6, 2024

Two different brands of intravenous immunoglobulin have been investigated, finding Brand P led to significantly longer durations of fever and hospitalization when compared to brand T.

Hospitals 132

Hospitals 132

Pharmacy Times

AUGUST 6, 2024

An overview of acid reflux and gastroesophageal reflux disease, over-the-counter options, long-term effects of proton pump inhibitors, lifestyle recommendations, and when to refer patients.

123

123

Fierce Pharma

AUGUST 6, 2024

Servier has expanded its IDH drug armamentarium with the FDA approval for an IDH1/2 dual inhibitor. | Servier's Voranigo, or vorasidenib, is now the first systemic therapy for low-grade IDH-mutant brain cancer.

FDA 126

FDA 126

Pharmacy Times

AUGUST 6, 2024

Improvements were observed in both the intervention and control group, with those who had self-reported learning difficulties showing the least improvement.

131

131

STAT

AUGUST 6, 2024

Roche, the Swiss pharmaceutical giant, earlier this year abruptly cancelled an international clinical trial of a drug being studied to treat children with a rare genetic disorder, citing “trade-offs made … to increase the overall portfolio value.” The news stunned parents of children enrolled in the Phase 2 study, as well as the academic researchers running it.

144

144

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

AUGUST 6, 2024

Discover how the innovative geko device is driving clinical change in UK stroke care. Learn how this technology is revolutionising the treatment and management of stroke patients.

131

131

Fierce Healthcare

AUGUST 6, 2024

FDA releases roster of digital health advisory committee, chaired by American College of Cardiology innovation officer ebeavins Tue, 08/06/2024 - 10:26

FDA 133

FDA 133

Fierce Pharma

AUGUST 6, 2024

Warning of a "silent pandemic" spreading across the globe, Pfizer is taking the fight against antimicrobial resistance (AMR) Down Under. | Pfizer announced Tuesday that it has invested 150 million Australian dollars (about $98 million) to build a new manufacturing facility at its Australian site in Melbourne, where the company will help produce new antimicrobial treatments aimed at addressing the rising tide of antimicrobial resistance.

132

132

Fierce Healthcare

AUGUST 6, 2024

UnitedHealthcare will launch a national program Oct. 1 for physicians to override traditional prior authorization requirements. | Physician practices in good standing will be able to skip prior authorization for some services, the insurer recently announced.

Insurance 120

Insurance 120

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

AUGUST 6, 2024

Acalabrutinib plus venetoclax, with or without obinutuzumab, demonstrated significant improvements in progression-free survival.

132

132

STAT

AUGUST 6, 2024

Retirements from the Food and Drug Administration are hardly shocking, especially in the wake of pandemic burnout. But when longtime medical device director Jeff Shuren announced his departure in July, the device world was stunned. Industry leaders, patient advocates, and FDA colleagues alike had grown accustomed to the ambitious, politically-savvy regulator.

FDA 127

FDA 127

pharmaphorum

AUGUST 6, 2024

Discover how Step Pharma is harnessing genetics and developing therapeutics targeting CTPS1 to advance cancer research and enhance clinical success. Learn more about their innovative approach.

119

119

STAT

AUGUST 6, 2024

Alcohol policy researchers are fuming over a letter sent by members of Congress last month, which criticizes a panel of experts charged with assessing the health risks of drinking alcohol. The letter reflects some of the tensions arising as federal health officials revise dietary guidelines for Americans based on a review of research, including mounting evidence of alcohol-related harms.

125

125

Pharmacy Times

AUGUST 6, 2024

Sunobinop binds to and activate nociception/orphanin-FQ peptide receptor, which is a known therapeutic target for substance use disorder.

121

121

Fierce Healthcare

AUGUST 6, 2024

This week on “Podnosis” we're discussing a new payment model that could affect thousands o | This week on “Podnosis” we're discussing a new payment model that could affect thousands of hospitals across the country. It's called TEAM, and it stands for Transforming Episode Accountability Model. It's a mandatory bundled payment program that covers five common procedures.

Hospitals 109

Hospitals 109

STAT

AUGUST 6, 2024

Life science venture capital firms are pacing for another record-low year of fundraising, potentially hindering the amount of money that startups can draw from over the next several years. In the first half of the year, the industry’s VC firms have raised just 15 pools of capital from wealthy individuals, sovereign wealth funds, pension funds, or university endowments.

139

139

Pharmafile

AUGUST 6, 2024

Patients treated with tafamidis were associated with greater rates of survival compared with patients untreated with tafamidis. Walton Oaks, 6th August 2024 – Pfizer Ltd today announced publication of real-world results from a cohort of the longitudinal, observational Phase 4 THAOS (Transthyretin Amyloidosis Outcomes Survey) study evaluating survival rates among patients with transthyretin cardiac amyloidosis (ATTR-CM) treated […] The post New Real-World Data Published in Journal of Cardia

105

105

The Checkup by Singlecare

AUGUST 6, 2024

Naproxen, most commonly sold under the brand names Aleve , Naprosyn , and Anaprox , is one of the most popular pain relievers available. It’s widely prescribed to treat certain types of acute and chronic pain, and it can also be purchased over the counter (OTC) in lower doses. It works by reducing prostaglandins, which are substances that trigger pain and inflammation.

Dosage 105

Dosage 105

Fierce Healthcare

AUGUST 6, 2024

The country’s four historically Black medical schools have received a total of $600 million in an investment by Bloomberg Philanthropies. | The funding will go to Meharry Medical College, Charles R. Drew University of Medicine and Science, Howard University College of Medicine and Morehouse School of Medicine. The foundation also gave seed funding to help start a new medical school at Xavier University of Louisiana in New Orleans -- a collaboration between Xavier and Ochsner Health.

Medical Schools 104

Medical Schools 104

STAT

AUGUST 6, 2024

The U.S. Congress needs help. It lacks the expertise to do its job in the post-Chevron world. At the end of its most recent term, the Supreme Court cast aside in a 6-3 decision the Chevron deference , which for 40 years required judges to defer to reasonable interpretations by federal agencies of the laws they are charged with administering. To legislate effectively without the Chevron deference, Congress will have to enact laws that leave far less room for interpretation.

123

123

Fierce Pharma

AUGUST 6, 2024

After previously floating the possibility of div | After previously floating the possibility of divesting Roctavian, BioMarin has decided to keep the hemophilia A gene therapy—but with a narrowed focus. The reorg comes with cost cuts across the medicine's R&D, manufacturing and commercialization support functions.

105

105

STAT

AUGUST 6, 2024

Arie Belldegrun has yet another job: He wants to be your lender. On Tuesday, Belledegrun and his team announced they have raised more than $600 million for a new life science credit firm called Symbiotic Capital. Symbiotic said it will provide loans to biotechs, companies manufacturing medical devices and health care tools, sequencing firms, and synthetic biology companies, and more.

117

117

The Checkup by Singlecare

AUGUST 6, 2024

For those managing diabetes or seeking weight loss options, Wegovy or metformin may be potential options. Both prescription medications have been shown to benefit blood sugar levels and body weight. Although they have similar benefits, they contain different active ingredients and work differently. They also have differences in their approved uses, costs, and side effects.

Dosage 97

Dosage Labelling Insurance Insurance Coverage 97

pharmaphorum

AUGUST 6, 2024

Bristol-Myers Squibb has handed back rights to a TIGIT drug partnered with Agenus, ending an alliance that could have been worth up to $1.56 billion to the biotech.Agenus revealed BMS' decision in a Securities & Exchange Commission (SEC) filing (PDF), saying it was a result of a "broader strategic realignment of their development pipeline which involves other licensed products.

111

111

Pharmacy Times

AUGUST 6, 2024

A report from SkyQuest Technology highlights the growth in the oncology and insulin spaces, indicating they will contribute to the most growth.

139

139

pharmaphorum

AUGUST 6, 2024

There's a new source of funding for life science companies, Symbiotic Capital, which is providing credit as an alternative to other financing routes

111

111

Fierce Pharma

AUGUST 6, 2024

As sales from COVID-19 vaccines continue to flounder, lawsuits associated with the products keep on piling up. | The university accused Pfizer's Comirnaty partner of failing to pay the full total of royalties owed on worldwide product sales through a sublicense agreement to Penn's mRNA patents.

Vaccines 115

Vaccines 115

pharmaphorum

AUGUST 6, 2024

Explore the latest updates and collaborations between the Gates Foundation, UCL, DSRU and more in the May-June 2024 issue of Changing Faces. Learn about their impactful work in government, non-profit, and professional organisation sectors.

110

110

Drug Topics

AUGUST 6, 2024

See what’s trending in pharmacy with a preview of the Total Pharmacy August issue.

112

112